Works matching AU Brouwers, Adrienne H.
Results: 85
The effects of molar activity on [<sup>18</sup>F]FDOPA uptake in patients with neuroendocrine tumors.
- Published in:
- EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00829-z
- By:
- Publication type:
- Article
Optimization of parathyroid <sup>11</sup>C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism.
- Published in:
- EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0534-5
- By:
- Publication type:
- Article
Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative <sup>18</sup>F-FDG PET/CT analysis.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0453-x
- By:
- Publication type:
- Article
Bone Mineral Density in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma: A Longitudinal Follow-Up Study.
- Published in:
- Thyroid, 2021, v. 31, n. 11, p. 1707, doi. 10.1089/thy.2021.0179
- By:
- Publication type:
- Article
Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma.
- Published in:
- Thyroid, 2020, v. 30, n. 8, p. 1169, doi. 10.1089/thy.2019.0560
- By:
- Publication type:
- Article
Clinical Applicability of Low Levels of Thyroglobulin Autoantibodies as Cutoff Point for Thyroglobulin Autoantibody Positivity.
- Published in:
- Thyroid, 2019, v. 29, n. 1, p. 71, doi. 10.1089/thy.2018.0195
- By:
- Publication type:
- Article
The value of <sup>18</sup>F-FDG PET/CT and <sup>18</sup>F-DOPA PET/CT in determining the initial surgical strategy of patients with medullary thyroid cancer: Preoperative PET/CT imaging for medullary thyroid cancer.
- Published in:
- Cancer Imaging, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s40644-025-00862-4
- By:
- Publication type:
- Article
Ultra‐low dose CT scanning for PET/CT.
- Published in:
- Medical Physics, 2024, v. 51, n. 1, p. 139, doi. 10.1002/mp.16862
- By:
- Publication type:
- Article
Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry Calculations.
- Published in:
- Molecular Imaging & Biology, 2023, v. 25, n. 2, p. 435, doi. 10.1007/s11307-022-01775-5
- By:
- Publication type:
- Article
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-023-00610-6
- By:
- Publication type:
- Article
Long-Term Quality of Life in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Convolutional neural networks for automatic image quality control and EARL compliance of PET images.
- Published in:
- EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00468-w
- By:
- Publication type:
- Article
Use of population input functions for reduced scan duration whole-body Patlak 18F-FDG PET imaging.
- Published in:
- EJNMMI Physics, 2021, v. 8, n. 1, p. 1, doi. 10.1186/s40658-021-00357-8
- By:
- Publication type:
- Article
Volume of interest delineation techniques for <sup>18</sup>F-FDG PET-CT scans during neoadjuvant extremity soft tissue sarcoma treatment in adults: a feasibility study.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0397-1
- By:
- Publication type:
- Article
PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230901
- By:
- Publication type:
- Article
Improved Localization of Insulinomas Using <sup>68</sup>Ga-NODAGA-Exendin-4 PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 12, p. 1959, doi. 10.2967/jnumed.124.268158
- By:
- Publication type:
- Article
Ultrashort Oncologic Whole-Body [<sup>18</sup>F]FDG Patlak Imaging Using LAFOV PET.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 10, p. 1652, doi. 10.2967/jnumed.124.267784
- By:
- Publication type:
- Article
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 10, p. 1540, doi. 10.2967/jnumed.124.267636
- By:
- Publication type:
- Article
Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1815, doi. 10.2967/jnumed.123.265621
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1944, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244640
- By:
- Publication type:
- Article
Assessment of Bone Lesions with <sup>18</sup>F-FDG-PET Compared to <sup>99m</sup>Technetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244640
- By:
- Publication type:
- Article
Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.244640
- By:
- Publication type:
- Article
Assessment of Bone Lesions with <sup>18</sup>F-FDG-PET Compared to <sup>99m</sup>Technetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.244640
- By:
- Publication type:
- Article
Long-Term Effects of Radioiodine Treatment on Salivary Gland Function in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 2, p. 172, doi. 10.2967/jnumed.118.212449
- By:
- Publication type:
- Article
Molecular Imaging in Cancer Drug Development.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 5, p. 726, doi. 10.2967/jnumed.116.188045
- By:
- Publication type:
- Article
Shortened duration whole body <sup>18</sup>F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function.
- Published in:
- EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00504-9
- By:
- Publication type:
- Article
Lymphatic drainage patterns of oral maxillary tumors: Approachable locations of sentinel lymph nodes mainly at the cervical neck level.
- Published in:
- Head & Neck, 2017, v. 39, n. 3, p. 486, doi. 10.1002/hed.24628
- By:
- Publication type:
- Article
False positive spinal cord uptake on fluorodeoxyglucose positron-emission tomography following treatment of lymphoma.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 5, p. 497, doi. 10.1111/bjh.12057
- By:
- Publication type:
- Article
Theranostics Using Antibodies and Antibody-Related Therapeutics.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, p. 83S, doi. 10.2967/jnumed.116.186940
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 6, p. 905, doi. 10.2967/jnumed.116.183475
- By:
- Publication type:
- Article
Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 11, p. 1685, doi. 10.2967/jnumed.115.169888
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 8, p. 1244, doi. 10.2967/jnumed.115.167643
- By:
- Publication type:
- Article
<sup>124</sup>I PET/CT to Predict the Outcome of Blind <sup>131</sup>I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET).
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 5, p. 701, doi. 10.2967/jnumed.115.168138
- By:
- Publication type:
- Article
In Vivo Biodistribution of No-Carrier-Added 6-<sup>18</sup>F-Fluoro-3, 4-Dihydroxy-L-Phenylalanine (<sup>18</sup>F-DOPA), Produced by a New Nucleophilic Substitution Approach, Compared with Carrier-Added <sup>18</sup>F-DOPA, Prepared by Conventional Electrophilic Substitution.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 106, doi. 10.2967/jnumed.114.145730
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 63, doi. 10.2967/jnumed.114.144840
- By:
- Publication type:
- Article
Everolimus Reduces <sup>89</sup>Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 7, p. 1087, doi. 10.2967/jnumed.113.129056
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET Imaging in Primary Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 7, p. 1014, doi. 10.2967/jnumed.112.117218
- By:
- Publication type:
- Article
Clinical Relevance of <sup>18</sup>F-FDG PET and <sup>18</sup>F-DOPA PET in Recurrent Medullary Thyroid Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 12, p. 1863, doi. 10.2967/jnumed.112.105940
- By:
- Publication type:
- Article
Total Abdominal <sup>18</sup>F-FDG Uptake Reflects Intestinal Adenoma Burden in Apc Mutant Mice.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 3, p. 431, doi. 10.2967/jnumed.110.083956
- By:
- Publication type:
- Article
6-L-<sup>18</sup>F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 4, p. 573, doi. 10.2967/jnumed.107.045708
- By:
- Publication type:
- Article
In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft.
- Published in:
- Journal of Nuclear Medicine, 2007, v. 48, n. 8, p. 1313, doi. 10.2967/jnumed.107.041301
- By:
- Publication type:
- Article
Carcinoid Crisis After Injection of 6-<sup>18</sup>F-Fluorodihydroxyphenylalanine in a Patient with Metastatic Carcinoid.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 7, p. 1240
- By:
- Publication type:
- Article
Optimization of Radioimmunotherapy of Renal Cell Carcinoma: Labeling of Monoclonal Antibody cG250 with <sup>131</sup>I, <sup>90</sup>Y, <sup>177</sup>Lu, or <sup>186</sup>Re.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 2, p. 327
- By:
- Publication type:
- Article
Advances and challenges in immunoPET methodology.
- Published in:
- Frontiers in Nuclear Medicine, 2024, p. 01, doi. 10.3389/fnume.2024.1360710
- By:
- Publication type:
- Article
Advances and challenges in immunoPET methodology.
- Published in:
- Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2024.1360710
- By:
- Publication type:
- Article